Although treatment with GEM or adoptive transfer of peptide A2-5 vaccinated CD8+ T cells provided significant anti-tumor effects, combination of these two treatments reduced the tumor size more dramatically and more effectively prolonged mice survival (Figure 5B and 5C). The gene discussed is CD8A; the disease is neoplasm.